Accueil>>Signaling Pathways>> Proteases>> MALT1>>MALT1 inhibitor MI-2

MALT1 inhibitor MI-2

Catalog No.GC36534

Inhibiteur de MALT1 Le MI-2 est un inhibiteur de MALT1 (IC50=5,84 μM). L'inhibiteur de MALT1 MI-2 se lie directement À MALT1, supprime de manière irréversible la fonction de protéase et s'accompagne d'une suppression de l'activité du rapporteur NF-κB, d'une inhibition de la localisation nucléaire c-REL et d'une régulation négative du gène cible NF-κB. L'inhibiteur de MALT1 MI-2 se montre non toxique pour les animaux.

Products are for research use only. Not for human use. We do not sell to patients.

MALT1 inhibitor MI-2 Chemical Structure

Cas No.: 1047953-91-2

Taille Prix Stock Qté
10mM (in 1mL DMSO)
112,00 $US
En stock
5mg
102,00 $US
En stock
10mg
135,00 $US
En stock
50mg
445,00 $US
En stock
100mg
797,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

MALT1 inhibitor MI-2 is a MALT1 inhibitor (IC50=5.84 μM). MALT1 inhibitor MI-2 binds directly to MALT1, irreversibly suppresses protease function and is accompanied by NF-κB reporter activity suppression, c-REL nuclear localization inhibition, and NF-κB target gene downregulation. MALT1 inhibitor MI-2 shows nontoxic to mice[1]. IC50: 5.84 μM (MALT1)[1]

MALT1 inhibitor MI-2 (1-1000 nM; 48 hours) selectively suppresses MALT1-dependent DLBCL cell lines, and the GI50 in HBL-1, TMD8, OCI-Ly3, and OCI-Ly10 cells is 0.2, 0.5, 0.4, and 0.4 µM, respectively[1].MALT1 inhibitor MI-2 (62-1000 nM; 24 hours) causes a dose-dependent decrease in MALT1-mediated cleavage[1]. Cell Proliferation Assay[1] Cell Line: HBL-1, TMD8, OCI-Ly3, OCI-Ly10 cells

MALT1 inhibitor MI-2 (25 mg/kg; i.p.; daily for 14 days) profoundly suppresses the growth of both the TMD8 and HBL-1 ABC-DLBCL xenografts[1]. Animal Model: Eight-week-old male SCID NOD (bearing HBL-1 and TMD8 cells)[1]

[1]. Fontan L, et al. MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo. Cancer Cell. 2012 Dec 11;22(6):812-24.

Avis

Review for MALT1 inhibitor MI-2

Average Rating: 5 ★★★★★ (Based on Reviews and 11 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for MALT1 inhibitor MI-2

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.